| Product Code: ETC7731645 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Arthritis Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Arthritis Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Arthritis Market - Industry Life Cycle |
3.4 Japan Arthritis Market - Porter's Five Forces |
3.5 Japan Arthritis Market Revenues & Volume Share, By Rheumatoid Drug Type, 2021 & 2031F |
3.6 Japan Arthritis Market Revenues & Volume Share, By Rheumatoid Treatment, 2021 & 2031F |
3.7 Japan Arthritis Market Revenues & Volume Share, By Rheumatoid Diagnosis, 2021 & 2031F |
3.8 Japan Arthritis Market Revenues & Volume Share, By Osteoarthritis Type, 2021 & 2031F |
3.9 Japan Arthritis Market Revenues & Volume Share, By Osteoarthritis Diagnosis, 2021 & 2031F |
3.10 Japan Arthritis Market Revenues & Volume Share, By Osteoarthritis Treatment, 2021 & 2031F |
3.11 Japan Arthritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Japan Arthritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of arthritis in Japan due to an aging population |
4.2.2 Growing awareness about arthritis treatment options and therapies |
4.2.3 Technological advancements in arthritis treatment leading to better outcomes |
4.3 Market Restraints |
4.3.1 High cost associated with arthritis medications and treatments |
4.3.2 Limited access to specialized healthcare services for arthritis patients in rural areas |
4.3.3 Regulatory challenges impacting the introduction of new arthritis treatments |
5 Japan Arthritis Market Trends |
6 Japan Arthritis Market, By Types |
6.1 Japan Arthritis Market, By Rheumatoid Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Arthritis Market Revenues & Volume, By Rheumatoid Drug Type, 2021- 2031F |
6.1.3 Japan Arthritis Market Revenues & Volume, By Biologics, 2021- 2031F |
6.1.4 Japan Arthritis Market Revenues & Volume, By Non-Biologics, 2021- 2031F |
6.1.5 Japan Arthritis Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.6 Japan Arthritis Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.1.7 Japan Arthritis Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.1.8 Japan Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Arthritis Market, By Rheumatoid Treatment |
6.2.1 Overview and Analysis |
6.2.2 Japan Arthritis Market Revenues & Volume, By Synovectomy, 2021- 2031F |
6.2.3 Japan Arthritis Market Revenues & Volume, By Tendon Repair, 2021- 2031F |
6.2.4 Japan Arthritis Market Revenues & Volume, By Joint Fusion, 2021- 2031F |
6.2.5 Japan Arthritis Market Revenues & Volume, By Symptomatic Treatment, 2021- 2031F |
6.2.6 Japan Arthritis Market Revenues & Volume, By Intermediate Corticosteroid Therapies, 2021- 2031F |
6.2.7 Japan Arthritis Market Revenues & Volume, By DMARD Therapies, 2021- 2031F |
6.3 Japan Arthritis Market, By Rheumatoid Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Japan Arthritis Market Revenues & Volume, By C.R.P. Test, 2021- 2031F |
6.3.3 Japan Arthritis Market Revenues & Volume, By C.C.P., 2021- 2031F |
6.3.4 Japan Arthritis Market Revenues & Volume, By E.S.R. Test, 2021- 2031F |
6.4 Japan Arthritis Market, By Osteoarthritis Type |
6.4.1 Overview and Analysis |
6.4.2 Japan Arthritis Market Revenues & Volume, By Hip, 2021- 2031F |
6.4.3 Japan Arthritis Market Revenues & Volume, By Spinal, 2021- 2031F |
6.4.4 Japan Arthritis Market Revenues & Volume, By Knee, 2021- 2031F |
6.4.5 Japan Arthritis Market Revenues & Volume, By Foot and Ankle, 2021- 2031F |
6.4.6 Japan Arthritis Market Revenues & Volume, By Shoulder, 2021- 2031F |
6.4.7 Japan Arthritis Market Revenues & Volume, By Hand, 2021- 2031F |
6.5 Japan Arthritis Market, By Osteoarthritis Diagnosis |
6.5.1 Overview and Analysis |
6.5.2 Japan Arthritis Market Revenues & Volume, By Imaging, 2021- 2031F |
6.5.3 Japan Arthritis Market Revenues & Volume, By Joint Fluid Analysis, 2021- 2031F |
6.5.4 Japan Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Japan Arthritis Market, By Osteoarthritis Treatment |
6.6.1 Overview and Analysis |
6.6.2 Japan Arthritis Market Revenues & Volume, By Medication, 2021- 2031F |
6.6.3 Japan Arthritis Market Revenues & Volume, By Drugs, 2021- 2031F |
6.6.4 Japan Arthritis Market Revenues & Volume, By Assistive Devices, 2021- 2031F |
6.6.5 Japan Arthritis Market Revenues & Volume, By Surgery, 2021- 2031F |
6.6.6 Japan Arthritis Market Revenues & Volume, By Therapy, 2021- 2031F |
6.7 Japan Arthritis Market, By Route of Administration |
6.7.1 Overview and Analysis |
6.7.2 Japan Arthritis Market Revenues & Volume, By Oral, 2021- 2031F |
6.7.3 Japan Arthritis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.8 Japan Arthritis Market, By End-Users |
6.8.1 Overview and Analysis |
6.8.2 Japan Arthritis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.8.3 Japan Arthritis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.8.4 Japan Arthritis Market Revenues & Volume, By Medical Institutes, 2021- 2031F |
6.8.5 Japan Arthritis Market Revenues & Volume, By Medical Institutes, 2021- 2031F |
6.8.6 Japan Arthritis Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.8.7 Japan Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Arthritis Market Import-Export Trade Statistics |
7.1 Japan Arthritis Market Export to Major Countries |
7.2 Japan Arthritis Market Imports from Major Countries |
8 Japan Arthritis Market Key Performance Indicators |
8.1 Average waiting time for arthritis treatment appointments |
8.2 Number of arthritis patients opting for non-pharmacological therapies |
8.3 Adoption rate of new arthritis treatment technologies |
9 Japan Arthritis Market - Opportunity Assessment |
9.1 Japan Arthritis Market Opportunity Assessment, By Rheumatoid Drug Type, 2021 & 2031F |
9.2 Japan Arthritis Market Opportunity Assessment, By Rheumatoid Treatment, 2021 & 2031F |
9.3 Japan Arthritis Market Opportunity Assessment, By Rheumatoid Diagnosis, 2021 & 2031F |
9.4 Japan Arthritis Market Opportunity Assessment, By Osteoarthritis Type, 2021 & 2031F |
9.5 Japan Arthritis Market Opportunity Assessment, By Osteoarthritis Diagnosis, 2021 & 2031F |
9.6 Japan Arthritis Market Opportunity Assessment, By Osteoarthritis Treatment, 2021 & 2031F |
9.7 Japan Arthritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Japan Arthritis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Japan Arthritis Market - Competitive Landscape |
10.1 Japan Arthritis Market Revenue Share, By Companies, 2024 |
10.2 Japan Arthritis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here